ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,273.57
0.39%
Dow Jones
39,308.00
-0.06%
Gold vs US Dollar
2,364.445
0.33%
Brent Oil
87.305
-0.03%
Bitcoin
54,372.64
-4.57%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BELLUS Health Inc (BLU)

  7. BELLUS Health Inc (BLU) News

BELLUS Health (BLU)

BELLUS Health Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BLU
DateTimeSourceHeadlineSymbolCompany
30/01/202415:56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLUBELLUS Health Inc
14/08/202322:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLUBELLUS Health Inc
10/07/202313:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:BLUBELLUS Health Inc
28/06/202322:22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BLUBELLUS Health Inc
28/06/202322:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLUBELLUS Health Inc
28/06/202322:21Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BLUBELLUS Health Inc
28/06/202322:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLUBELLUS Health Inc
28/06/202321:57Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLUBELLUS Health Inc
28/06/202321:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:BLUBELLUS Health Inc
28/06/202321:10Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:BLUBELLUS Health Inc
28/06/202319:42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLUBELLUS Health Inc
28/06/202316:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
28/06/202316:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLUBELLUS Health Inc
28/06/202315:59PR Newswire (Canada)Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS SantéNASDAQ:BLUBELLUS Health Inc
28/06/202315:57PR Newswire (Canada)Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS HealthNASDAQ:BLUBELLUS Health Inc
16/06/202318:50Business WireBELLUS Health Inc. Announces Voting Results from Special Meeting of ShareholdersNASDAQ:BLUBELLUS Health Inc
16/06/202318:50Business WireBELLUS Santé inc. annonce les résultats du vote tenu à l’assemblée extraordinaire des actionnairesNASDAQ:BLUBELLUS Health Inc
06/06/202321:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
19/05/202322:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
16/05/202322:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
16/05/202322:01Business WireBELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK AcquisitionNASDAQ:BLUBELLUS Health Inc
16/05/202322:01Business WireBELLUS Santé inc. convoque une assemblée extraordinaire des actionnaires concernant l’acquisition de la société par GSKNASDAQ:BLUBELLUS Health Inc
12/05/202321:33Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
12/05/202321:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
12/05/202321:01Business WireBELLUS Santé annonce ses résultats financiers et faits saillants pour le premier trimestre de 2023NASDAQ:BLUBELLUS Health Inc
12/05/202321:01Business WireBELLUS Health Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:BLUBELLUS Health Inc
28/04/202316:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
27/04/202311:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
27/04/202311:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
26/04/202323:00Business WireBELLUS Health Announces Meeting UpdatesNASDAQ:BLUBELLUS Health Inc
 Showing the most relevant articles for your search:NASDAQ:BLU

Your Recent History

LSE
PFC
Petrofac
LSE
POS
Plexus
LSE
ENET
Ethernity Networks
LSE
LLOY
Lloyds Banking
LSE
GCM
Gcm Resources
LSE
AAZ
Anglo Asian Mining
LSE
BARC
Barclays
LSE
HE1
Helium One Global
LSE
RKH
Rockhopper Exploration
LSE
PIER
Brighton Pier
LSE
PIP
Pipehawk
LSE
GKP
Gulf Keystone Petroleum
LSE
EDEN
Eden Research
LSE
PALM
Panther Metals
LSE
ECR
Ecr Minerals
LSE
GOLD
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved